Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.

Abstract

The uniform use in Canada of a single Haemophilus influenzae type b conjugate vaccine in combination with diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccines (DTaP.IPV/Hib) facilitates ongoing assessment of vaccine effectiveness, including any effects of recently added concurrent vaccinations and increasing time since vaccination. Surveillance at 12 pediatric centers in 2004-2007 indicates that vaccine failures remain rare and case totals approach an irreducible minimum, with no age shift.

• Authors: David W Scheifele, Julie A Bettinger, Scott A Halperin, Barbara Law, Robert Bortolussi
• Journal: The Pediatric infectious disease journal (Pediatr Infect Dis J) Vol. 27 Issue 8 Pg. 755-7 (Aug 2008) ISSN: 0891-3668 [Print] United States
• PMID: 18594482 (Publication Type: Journal Article)

Chemical References

• Diphtheria-Tetanus-acellular Pertussis Vaccines
• Haemophilus Vaccines
• Haemophilus influenzae type b polysaccharide vaccine
• Poliovirus Vaccine, Inactivated
• Vaccines, Combined

Topics

• Adolescent
• Bacterial Capsules (administration & dosage, immunology)
• Canada (epidemiology)
• Child
• Child, Preschool
• Diphtheria-Tetanus-acellular Pertussis Vaccines (administration & dosage, immunology)
• Haemophilus Infections (epidemiology, prevention & control)
• Haemophilus Vaccines (administration & dosage, immunology)
• Haemophilus influenzae type b (immunology)
• Humans
• Immunization Programs
• Incidence
• Infant
• Infant, Newborn
• Poliovirus Vaccine, Inactivated (administration & dosage, immunology)
• Treatment Outcome
• Vaccines, Combined (administration & dosage, immunology)